First Horizon Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

First Horizon Advisors’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-30	Closed	-$471	–	2391
2024 Q1	$471	Hold	30	–	–	﹤0.01%	2227
2023 Q4	$483	Hold	30	–	–	﹤0.01%	2299
2023 Q3	$381	Sell	30 -35	-54%	-$483	﹤0.01%	2333
2023 Q2	$915	Hold	65	–	–	﹤0.01%	2286
2023 Q1	$1K	Hold	65	–	–	﹤0.01%	2262
2022 Q4	$1.06K	Buy	+65	New	+$1.06K	﹤0.01%	2223

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

First Horizon Advisors's DCPH Position: Q2 2024 in Review

First Horizon Advisors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 30 shares — an estimated $471 sold.

First Horizon Advisors first reported a position in DCPH in Q4 2022 and held it in 6 quarters. The position peaked at $1.06K in Q4 2022. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

First Horizon Advisors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
First Horizon Advisors sold 30 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $471.
First Horizon Advisors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 6 quarters.
First Horizon Advisors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.06K in Q4 2022.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on First Horizon Advisors's 13F filing for Q2 2024, filed 19 Jul 2024.